ArticleLeukemia2024

How to individualize therapy after failing milestones in chronic myeloid leukaemia: weighting late response and early death from CML against risk of alternative therapies.

Rüdiger Hehlmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.